LBX2 and ovarian carcinoma: To investigate whether LBX2‐AS1 could functionally inhibit miR‐455‐4p or miR‐491‐5p in ovarian cancer cells, we first evaluated the level of these two miRNAs in SKOV3 or OVCAR‐3 cells with or without LBX2‐AS1 knockdown.